HAS

STANFORD STUDENT SELECTED TO COMPETE IN THE 2024 OLYMPIC TRIALS FOR BOXING

Retrieved on: 
Thursday, November 9, 2023

PALO ALTO, Calif., Nov. 9, 2023 /PRNewswire/ -- Dante Kirkman, an undergraduate student at Stanford University and a native of Palo Alto, California, has been selected by USA Boxing to compete at the 2024 Olympic Trials for Boxing.

Key Points: 
  • DANTE KIRKMAN, STANFORD UNDERGRADUATE AND PALO ALTO NATIVE, HAS BEEN SELECTED FOR THE 2024 OLYMPIC TRIALS FOR BOXING
    PALO ALTO, Calif., Nov. 9, 2023 /PRNewswire/ -- Dante Kirkman, an undergraduate student at Stanford University and a native of Palo Alto, California, has been selected by USA Boxing to compete at the 2024 Olympic Trials for Boxing.
  • Stanford University student Dante Kirkman has been selected by USA Boxing to compete at 2024 Olympic Trials for Boxing.
  • Kirkman, age 22, is a USA Boxing Elite Level amateur boxer who has been nationally ranked multiple times.
  • Kirkman has already received professional contract offers but remains focused on advancing to represent the USA at the Olympic Games in Paris in 2024.

SAASTEPS Announces Deferred Payment Promotion to Support CRM Paradigm Shift

Retrieved on: 
Tuesday, November 7, 2023

BROOMFIELD, Colo., Nov. 7, 2023 /PRNewswire-PRWeb/ -- Most people have experienced multiple paradigm shifts in their lifetime, whether they were aware of it or not; shifting from brick-and-mortar stores to eCommerce, landlines to cell phones, and paper newspapers to digital content are all great examples. These shifts are rarely easy, as people and businesses who occupy existing paradigms are often reluctant to accept a change in their world view.

Key Points: 
  • SaaS disruptor SAASTEPS announces a limited-time promotion allowing new customers to implement their SAASRAM revenue management suite now and begin payments in Q1 2024.
  • These shifts are rarely easy, as people and businesses who occupy existing paradigms are often reluctant to accept a change in their world view.
  • On a much smaller scale, we are experiencing our own paradigm shift.
  • The SaaS world is changing, and strategic, nimble businesses are leaning into this less complex and way more affordable paradigm.

THE CENTER FOR DISCOVERY CEO PATRICK H. DOLLARD TO MOVE INTO SENIOR ADVISORY ROLE IN THE NEW YEAR

Retrieved on: 
Monday, October 16, 2023

HARRIS, N.Y., Oct. 16, 2023 /PRNewswire/ -- THE CENTER FOR DISCOVERY® (TCFD) TODAY ANNOUNCED THAT CHIEF EXECUTIVE OFFICER PATRICK H. DOLLARD, WHO HAS LED THE ORGANIZATION FOR 43 YEARS, HAS DECIDED TO TRANSITION INTO A NEW ROLE AS SENIOR ADVISOR. THE BOARD OF DIRECTORS IMMEDIATELY NAMED DR. THERESA HAMLIN, ITS PRESIDENT, TO SUCCEED HIM. THE CHANGES ARE EFFECTIVE AT THE START OF THE NEW YEAR. 

Key Points: 
  • I HAVE REALLY ENJOYED WORKING CLOSELY WITH HIM OVER THIS PAST DECADE AND THE BOARD IS DELIGHTED HE WILL CONTINUE TO SERVE AS A SENIOR ADVISOR.
  • AS PATRICK TRANSITIONS INTO A SENIOR ADVISORY ROLE, WE ARE FORTUNATE TO HAVE DR. THERESA HAMLIN ASSUME THE CEO POSITION AT THE START OF THE NEW YEAR."
  • "TODAY TCFD IS RECOGNIZED AS A NATIONAL CENTER OF EXCELLENCE THANKS TO PATRICK'S ADVOCACY AND THOUGHT LEADERSHIP OVER FOUR DECADES.
  • "WE ARE GRATEFUL TO PATRICK FOR HIS BOLD VISION AND LEADERSHIP, AND FORTUNATE TO HAVE SOMEONE AS QUALIFIED, ENTHUSIASTIC AND READY FOR THE FUTURE AS TERRY."

Biophytis releases its half-yearly accounts as of 30 June 2023 and provides an update on its operations

Retrieved on: 
Wednesday, September 27, 2023

As in the previous year, Biophytis did not record any revenues in the first half of 2023.

Key Points: 
  • As in the previous year, Biophytis did not record any revenues in the first half of 2023.
  • The change in net financial expense is mainly due to the valuation of financial liabilities in accordance with IFRS 9.
  • As a result of the above, the half-year loss has been significantly reduced, from €12.4 million at 30 June 2022 to €7.8 million at 30 June 2023.
  • Continuing pre-clinical development work on Macuneos (BIO201) and its back-up BIO203 and preparing for clinical development in dry AMD.

Biophytis provides an update on its early access programs for Sarconeos (BIO101) in the treatment of severe forms of COVID-19

Retrieved on: 
Monday, September 25, 2023

After examining the Early Access Authorization request file submitted at the end of May 2023, HAS considered that the Company had not provided sufficient data allowing it to evaluate precisely the benefit vs. risk ratio and to authorize the treatment of patients with severe forms of COVID-19, despite the statistically significant results of the phase 2-3 COVA study.

Key Points: 
  • After examining the Early Access Authorization request file submitted at the end of May 2023, HAS considered that the Company had not provided sufficient data allowing it to evaluate precisely the benefit vs. risk ratio and to authorize the treatment of patients with severe forms of COVID-19, despite the statistically significant results of the phase 2-3 COVA study.
  • At the same time, Biophytis is taking steps in Brazil to confirm the early access authorization obtained in early 2022 that was interrupted pending publication of the full results of the COVA study.
  • This new authorization is expected by the end of the year.
  • Finally, the Company is exploring the possibilities of launching early access programs in other key countries in Europe, in order to best respond to the medical need in a pathology that has become endemic.

Aviat Networks Secures $50 Million in Orders from Two New U.S. Statewide Public Safety Projects

Retrieved on: 
Thursday, September 21, 2023

AUSTIN, Texas, Sept. 21, 2023 /PRNewswire/ -- Aviat Networks, Inc. (NASDAQ: AVNW), the leading expert in wireless transport and access solutions, today announced it has received orders totaling over $50 Million with two separate U.S. State governments for statewide public safety networks.

Key Points: 
  • AUSTIN, Texas, Sept. 21, 2023 /PRNewswire/ -- Aviat Networks, Inc. (NASDAQ: AVNW), the leading expert in wireless transport and access solutions, today announced it has received orders totaling over $50 Million with two separate U.S. State governments for statewide public safety networks.
  • These projects involve a mix of high-power microwave radios, high availability routers, and management software along with turnkey services for design, installation, support, and ongoing managed services.
  • "It is our honor to support our first responders and we are grateful these U.S. State government agencies put their trust in Aviat," said Pete Smith, President and CEO, Aviat Networks.
  • "We are committed to providing mission-critical network functionality with highest reliability to deliver the advanced technology and services these customers require."

GE Aerospace selected by Bell for V-280 Valor Future Long-Range Assault Aircraft

Retrieved on: 
Thursday, September 7, 2023

GE Aerospace today announced the selection by Bell Textron Inc., a Textron company, for work on the development of a Common Open Architecture Digital Backbone (COADB), Voice and Data Recorder , and the Health Awareness System (HAS) for the Bell V-280 Valor.

Key Points: 
  • GE Aerospace today announced the selection by Bell Textron Inc., a Textron company, for work on the development of a Common Open Architecture Digital Backbone (COADB), Voice and Data Recorder , and the Health Awareness System (HAS) for the Bell V-280 Valor.
  • Following the U.S. Army’s Future Long-Range Assault Aircraft (FLRAA) program contract award, the V-280 Valor will enable the U.S. Army and its allies to maintain battlefield superiority including transformational capabilities in speed, range, payload, and endurance.
  • The GE Aerospace systems will be part of an open, scalable, high-speed data infrastructure consistent with the U.S. Army’s Modular Open Systems Approach (MOSA) that enables rapid testing, verification, and fielding of mission-focused capabilities for future vertical lift programs.
  • Bell and GE Aerospace are incorporating these advanced capabilities on the Bell V-280 Valor and Bell 360 Invictus as part of the FLRAA and FARA programs, and working with the Army to set the standards for quicker, more affordable upgrades in capability as technologies and mission requirements evolve.

The SBBRG Foundation Sponsors Heartland Animal Shelter

Retrieved on: 
Friday, August 18, 2023

Heartland Animal Shelter (HAS) received a donation from the SBB Research Group Foundation , which partners with local nonprofits through its Champion A Charity Program.

Key Points: 
  • Heartland Animal Shelter (HAS) received a donation from the SBB Research Group Foundation , which partners with local nonprofits through its Champion A Charity Program.
  • Heartland Animal Shelter believes it is of utmost importance to create a warm, safe, and comfortable space for their feline and canine residents.
  • Earlier this year, the SBBRG Foundation and the Heartland team joined forces to create fleece blankets for the dogs and cats of HAS in Wheeling, IL.
  • Beyond the heartwarming blanket-making activity, the SBBRG Foundation and Heartland Animal Shelter partnership encompasses broader initiatives.

Rhythm Pharmaceuticals Announces Pre-Marketing Early Access Authorization for Setmelanotide for Use in Patients with Hypothalamic Obesity in France

Retrieved on: 
Monday, August 7, 2023

BOSTON, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway diseases, today announced that the French National Agency for Medicines and Health Products Safety (ANSM) and French National Authority for Health (HAS) have granted pre-marketing early access authorization AP1 (Autorisation d’Accès Précoce), for IMCIVREE® (setmelanotide), an MC4R agonist, for patients with lesional hypothalamic obesity.

Key Points: 
  • Setmelanotide has been available through a similar program for patients in France with Bardet-Biedl syndrome (BBS) since July 2022.
  • Rhythm estimates there are approximately 500-2,000 patients living with hypothalamic obesity in France, with approximately 50 to 200 new cases each year.
  • In the United States, the Company estimates the prevalence in hypothalamic obesity to be approximately 5,000-10,000 patients with an annual incidence of approximately 500 new patients.
  • “This AP1 addresses a significant unmet need for patients with severe obesity and hyperphagia, two hallmark symptoms of hypothalamic obesity, for the first time.”

SP Plus Corporation Launches its AeroParker Online Booking Reservation System at George Bush Intercontinental, and William P. Hobby Airports

Retrieved on: 
Thursday, July 13, 2023

To fulfill the needs of The Houston Airport System (HAS) today, and in the future, SP+ recently implemented AeroParker, its online reservation system providing airport parking pre-booking functionality.

Key Points: 
  • To fulfill the needs of The Houston Airport System (HAS) today, and in the future, SP+ recently implemented AeroParker, its online reservation system providing airport parking pre-booking functionality.
  • "Through the launch of our AeroParker reservation system at IAH and HOU airports, we are proud to empower HAS with a trusted, scalable, secure, and user-friendly platform," said Alan Daring, VP Business Development, AeroParker.
  • “Houston Airports is delighted to offer our guests an intuitive and simple solution to their parking needs.
  • Our new online parking reservation system aligns with our commitment to delivering 5-Star customer service while guaranteeing parking availability,” said Walt Gray, Director of Parking and Ground Transportation for Houston Airports.